About the course

Are you a parent or clinician interested in understanding how health in the months before conception shapes pregnancy and neurodevelopment? This on-demand course offers a unique opportunity to learn directly from Richard E. Frye, MD, PhD, a child neurologist and leading researcher who has spent decades studying metabolic and mitochondrial dysfunction in neurodevelopmental disorders. This first course in the series introduces the framework the rest of it is built on: what the protocol is and is not, its three clinical modules, the two-tier testing structure, the four-level action framework that grades every test from standard care to research-only, and the five-step algorithm that ties them together.

About the Creator

Dr. Richard Frye is a Child Neurologist specializing in neurodevelopmental and neurometabolic disorders. He holds an MD and PhD from Georgetown University, completed residencies and fellowships at Harvard and Boston University, and is board-certified in Pediatrics and Neurology with Special Competence in Child Neurology. A national leader in autism research, Dr. Frye has authored over 300 peer-reviewed publications and led multiple clinical trials investigating metabolic and physiological treatments for ASD, including folinic acid. His current research focuses on metabolic endophenotypes and targeted therapies for ASD. In 2022, he co-founded The Autism Discovery and Treatment Foundation and continues to see patients in the U.S. and internationally.

Curriculum

    1. (Included in full purchase)
    1. (Included in full purchase)
    1. (Included in full purchase)
    1. (Included in full purchase)
    1. (Included in full purchase)
    1. (Included in full purchase)
    1. (Included in full purchase)
    1. (Included in full purchase)